Sarcomatrix, Inc. is pioneering novel therapeutics that leverage our understanding of muscle biology and tissue regeneration.
Sarcomatrix has raised $300K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2025.
Sarcomatrix's investors include Battle Born Venture.
Sarcomatrix is headquartered in San Francisco, United States.
Sarcomatrix, Inc. is pioneering novel therapeutics that leverage our understanding of muscle biology and tissue regeneration.
Sarcomatrix is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sarcomatrix — Funding & Investors." VCBacked, July 25, 2025, https://www.vcbacked.co/company/sarcomatrix. Accessed November 14, 2026.
VCBacked. (2025). Sarcomatrix — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/sarcomatrix
{{cite web |title=Sarcomatrix — Funding & Investors |url=https://www.vcbacked.co/company/sarcomatrix |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Sarcomatrix? Request a listing update